Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Settings and Recruitment
2.3. Data Collection
2.4. Data Analysis
2.5. Ethical Approval
3. Results
3.1. Demographic Characteristics of Interviewees
3.2. Factors Related to the Difficulties of Effective Prevention and Control of Hepatitis B and C in the Community
3.3. Participants’ Suggestions to Improve the Prevention and Control of Hepatitis B and C in the Community
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix
Key points | Quotes |
---|---|
Poor awareness and knowledge of HBV and HCV care among participants and strong stigma in the society | Quote 1: “I feel confused as to why my parents, who are both over 80, do not suffer from hepatitis B, but my brother and I experience such a condition.” (Patient-4) |
Quote 2: “Honestly, most of the HBV- and HCV-positive populations know little about the diseases; they are unaware of what they should do in a case that they become infected.” (Community leader-1) | |
Quote 3: “Actually, we do not concern about hepatitis, instead, we mostly focus on chronic diseases, like hypertension and diabetes, since there are more people ill with chronic diseases compared with hepatitis.” (Resident-4) | |
Quote 4: “Both the common citizens and medical workers possess inadequate common knowledge about hepatitis C. A number of people still confuse hepatitis C with hepatitis B, indicating their need to increase their knowledge about these diseases. Given the limited knowledge of patients with hepatitis B and C, early treatment has always been delayed, resulting in deteriorating conditions.” (CDC-2) | |
Quote 5: “I was a security guard in a company, but the boss fired me after I was diagnosed with hepatitis B. Afterward, I never found a stable job. Thus, my income is low. Discrimination also arises in the family sometimes. For example, when I eat, some family members become very angry if I use their tableware inadvertently.” (Patient-5) | |
Quote 6: “I experienced a situation like this: one resident who was over 50 years old was found to be a hepatitis B carrier in an operation. Since then, he had to eat alone, and his son and daughter-in-law forbade him to hug his grandson, which caused a significant psychological burden to him.” (CHC-1) | |
Inadequate health education about hepatitis B and C in the community | Quote 7: “In general, little attention is given to viral hepatitis in the community. I receive no relevant health promotional materials, such as leaflets or posters, nor see related display board in the community.” (Resident-3) |
Quote 8: “Occasionally, the doctors from community health service centers would mention some information about viral hepatitis when conducting health education activities on chronic diseases.” (Community leader-2) | |
Low-level services currently provided to treat patients with hepatitis B and C | Quote 9: “How to achieve effective bidirectional referral needs more push from the government!” (CHC-1) |
Quote 10: “Usually, we advise hepatitis patients or original residents to disinfect the tableware and pay attention to personal hygiene, but we know nothing about treating patients professionally.” (Doctor from community health service center-1) | |
Quote 11: “The antiviral and hepatoprotective drugs are not in the list of basic medicine. As a consequence, hepatitis patients are unable to obtain treatment in community health centers. However, treatment and follow-up of patients in the community health centers are more convenient.” (Community leader-2) | |
Strengthen health education | Quote 12: “We hope to receive one lesson for us every month. The lessons should tell us what kind of treatment we should get and how or what kind of foods are good for treating the disease. Moreover, the community can occasionally offer medical examinations when conducting health education activities.” (Patient-1) |
Quote 13: “Participatory activities, such as climbing, and gifts should be organized and prepared as rewards can motivate more residents to join the activities. Otherwise, they will not partake in the activities.” (Resident-2) | |
Quote 14: “I think we should seize the opportunity for schools and enterprises to carry out collective activities, for example, we can process a 20-minute publicity when schools open the parents’ meeting or when enterprises initiate staff meetings.” (Community leader-1) | |
Quote 15: “The community health activists can inform us about health education activities. We will join these activities if available. Community health activists also care about us and relieve our mental burden to a certain extent.” (Patient-2) | |
Improve services for treating patients with hepatitis B and C | Quote 16: “The three-stage prevention of viral hepatitis must be emphasized, for example, hepatitis B examination should be included in health examination items to increase the discovery rate.” (CDC-3) |
References
- World Health Organization. World Hepatitis Day 2018: Test. Treat. Hepatitis. Available online: http://www.who.int/who-campaigns/world-hepatitis-day/2018 (accessed on 30 July 2018).
- World Health Organization. News and Events, WHO Calls for Better Monitoring of Viral Hepatitis and Liver Cancer. Available online: http://www.who.int/hepatitis/news-events/hepatitis-surveillance-protocol-story/en/ (accessed on 4 May 2018).
- World Health Organization. The Global Hepatitis Report, 2017. Available online: http://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf?sequence=1 (accessed on 4 May 2018).
- World Health Organization. Event Announcement, World Hepatitis Day 2017: Eliminate Hepatitis. Available online: http://www.who.int/campaigns/hepatitis-day/2017/event/en/ (accessed on 4 May 2018).
- Wang, F.S.; Fan, J.G.; Zhang, Z.; Gao, B.; Wang, H.Y. The global burden of liver disease: The major impact of China. Hepatology 2015, 60, 2099–2108. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Available online: http://apps.who.int/iris/bitstream/handle/10665/154590/9789241549059_eng.pdf?sequence=1 (accessed on 23 July 2018).
- Yan, Y.P.; Su, H.X.; Ji, Z.H.; Shao, Z.J.; Pu, Z.S. Epidemiology of Hepatitis B Virus Infection in China: Current Status and Challenges. J. Clin. Transl. Hepatol. 2014, 2, 15–22. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, M.; Katayama, F.; Kato, H.; Tanaka, H.; Wang, J.; Qiao, Y.L.; Inoue, M. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures. J. Epidemiol. 2011, 21, 401–416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ministry of Health, China. National Plan for Prevention and Treatment against Hepatitis B for 2006–2010. Available online: http://www.nhfpc.gov.cn/zwgk/jdjd/201304/72ea886b4f6c416fae8bdb38634b0620.shtml (accessed on 28 July 2018).
- Kiyohara, T.; Ishii, K.; Mizokami, M.; Sugiyama, M.; Wakita, T. Seroepidemiological study of hepatitis B virus markers in Japan. Vaccine 2015, 33, 6037–6042. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, J.; Akita, T.; Ohisa, M.; Sakamune, K.; Ko, K.; Uchida, S.; Satake, M. Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011. J. Viral. Hepatitis 2017, 25, 363–372. [Google Scholar] [CrossRef]
- Ang, L.W.; Cutter, J.; James, L.; Goh, K.T. Seroepidemiology of hepatitis B virus infection among adults in Singapore: A 12-year review. Vaccine 2013, 32, 103–110. [Google Scholar] [CrossRef]
- André, F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000, 18 (Suppl. 1), S20–S22. [Google Scholar] [CrossRef]
- Waheed, Y.; Binrahat, T.; Safi, S.Z.; Qadri, I. Epidemiological patterns and risk factors associated with hepatitis B virus in Pakistani population. Asian Biomed. 2011, 4, 547–554. [Google Scholar] [CrossRef]
- Al, Z.K.; Mahmud, S.; Kouyoumjian, S.P.; AbuRaddad, L.J. The epidemiology of hepatitis C virus in Pakistan: Systematic review and meta-analyses. Int. J. Infect. Dis. 2015, 40, 54–63. [Google Scholar] [CrossRef]
- Cao, W.W.; Zhou, R.R.; Ou, X.; Shi, L.X.; Xiao, C.Q.; Chen, T.Y.; Tan, H.; Fan, X.G.; Li, B.J.; Li, N. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016. BMC Infect. Dis. 2018, 18, 145. [Google Scholar] [CrossRef]
- Cui, Y.; Jia, J. Update on epidemiology of hepatitis B and C in China. J. Gastroenterol. Hepatol. 2013, 28, 7–10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, G.T.; Si, C.W.; Wang, Q.H.; Chen, L.H.; Chen, H.S.; Xu, D.Z.; Zhang, L.X.; Wang, B.E.; Wang, L.T.; Li, Y. Comments on the prevention and research of chronic hepatitis in China. J. Natl. Med. J. China 2002, 82, 74–76. [Google Scholar]
- Liu, Z.; Yang, Q.; Shi, O.; Ye, W.; Chen, X.; Zhang, T. The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study. J. Viral Hepatitis 2018, 25, 1543–1554. [Google Scholar] [CrossRef] [PubMed]
- Zeng, F.; Guo, P.; Huang, Y.; Xin, W.; Du, Z.; Zhu, S.; Deng, Y.; Zhang, D.; Hao, Y. Epidemiology of hepatitis B virus infection: Results from a community-based study of 0.15 million residents in South China. Sci. Rep. 2016, 6, 36186. [Google Scholar] [CrossRef] [PubMed]
- Zhu, B.; Liu, J.; Fu, Y.; Zhang, B.; Mao, Y. Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003–2015): Implications for Prevention and Control Policies. Int. J. Environ. Res. Public Health 2018, 15, 661. [Google Scholar] [CrossRef] [PubMed]
- Kim, W.R.; Ward, J.W.; Cheever, L.W.; Dan, C.; Dee, L.; Zola, J. Transforming the current infrastructure for combating HBV and HCV infections. J. Fam. Pract. 2010, 59 (Suppl. 4), 65–70. [Google Scholar] [CrossRef]
- World Health Organization. News, Fact Sheet: Hepatitis B. Available online: http://www.who.int/news-room/fact-sheets/detail/hepatitis-b (accessed on 4 May 2018).
- World Health Organization. News and Events, Progress Toward Access to Hepatitis B Treatment Worldwide. Available online: http://www.who.int/hepatitis/news-events/cdc-hepatitis-b-article/en/ (accessed on 28 July 2018).
- World Health Organization. News, Fact Sheet: Hepatitis C. Available online: http://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed on 4 May 2018).
- The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. J. Lancet Gastroenterol. Hepatol. 2017, 2, 161–176. [Google Scholar] [CrossRef]
- Sun, Y.T.; Zhang, Y.X.; Tang, H.; Mao, Q.; Wang, X.Z.; Zhang, L.Y.; Chen, H.; Zhong, Y.N.; Lin, S.M.; Zhang, D.Z. Clinical characteristics and current management of hepatitis B and C in China. World J. Gastroenterol. 2014, 20, 13582–13590. [Google Scholar] [CrossRef] [PubMed]
- Chen, E.Q.; Ma, Y.J.; Wang, J.; He, F.; Zhou, T.Y.; Ji, Y.L.; Tang, H. Prevalence of hepatitis B virus infection in western China: Epidemiological survey results of general adult population. Future Virol. 2018, 13, 629–636. [Google Scholar] [CrossRef]
- Guest, G.; Bunce, A.; Johnson, L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006, 18, 59–82. [Google Scholar] [CrossRef]
- Chao, J.; Chang, E.T.; So, S.K. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: A cross-sectional study. J. BMC Public Health 2010, 10, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Health Consumer Powerhouse. Euro Hepatitis Index Report. 2012. Available online: https://old.healthpowerhouse.com/files/euro-hepatitis-index-2012/Report-Hepl-HCP-121104-2-w-Cover.pdf (accessed on 3 August 2018).
- Brouard, C.; Gautier, A.; Saboni, L.; Jestin, C.; Semaille, C.; Beltzer, N. Hepatitis B knowledge, perceptions and practices in the French general population: The room for improvement. BMC Public Health 2013, 13, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Odimayo, M.S.; Nwadioha, S.I.; Utoo, P.M. Level of awareness of hepatitis B viral infection among a subset of Makurdi community in Benue State, Nigeria. Br. Microbiol. Res. J. 2015, 7, 28–34. [Google Scholar] [CrossRef]
- Varaldo, C.N.; Costa, J.; Pascom, A.R.; Postigo, V.M. P1275: Stigma and discrimination in viral hepatitis—The voice of the patient. J. Hepatol. 2015, 62, S837. [Google Scholar] [CrossRef]
- Melbourne: Australian Research Centre in Sex, Health & Society. Stigma, discrimination and hepatitis B: A Review of Current Research. 2013. Available online: http://arrow.latrobe.edu.au:8080/vital/access/manager/Repository/latrobe:35658 (accessed on 28 July 2018).
- Wallace, J.; McNally, S.; Richmond, J.; Hajarizadeh, B.; Pitts, M. Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia. Sex Health 2012, 9, 131–137. [Google Scholar] [CrossRef] [PubMed]
- Wallace, J.; McNally, S.; Richmond, J.; Hajarizadeh, B.; Pitts, M. Managing chronic hepatitis B: A qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia. BMC Res. Notes 2011, 4, 1–7. [Google Scholar] [CrossRef]
- Ringelhan, M.; McKeating, J.A.; Protzer, U. Viral hepatitis and liver cancer. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2017, 372. [Google Scholar] [CrossRef]
- Fourati, S.; Feld, J.J.; Chevaliez, S.; Luhmann, N. Approaches for simplified HCV diagnostic algorithms. J. Int. AIDS Soc. 2018, 21 (Suppl. 2), e25058. [Google Scholar] [CrossRef] [PubMed]
- Barbosa, J.R.; Cortes, V.F.; Portilho, M.M.; Miguel, J.C.; Marques, V.A.; Bezerra, C.S.; de Souza, N.V.; Lima, D.M.; Colares, J.K.B.; Lewis-Ximenez, L.L.; et al. Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients. J. Clin. Pathol. 2018, 71, 879. [Google Scholar] [CrossRef]
- Shivkumar, S.; Peeling, R.; Jafari, Y.; Joseph, L.; Pant, N.P. Accuracy of rapid and point-of-care screening tests for hepatitis C: A systematic review and meta-analysis. Ann. Intern. Med. 2012, 157, 558–566. [Google Scholar] [CrossRef]
Interviewee | Age | Sex | Location |
---|---|---|---|
Patient-1, Hepatitis C, under treatment | 59 | Male | Chengdu |
Patient-2, Chronic hepatitis B, under treatment | 49 | Male | Chengdu |
Patient-3, Chronic hepatitis B, under treatment | 45 | Female | Chengdu |
Patient-4, Chronic hepatitis B, under treatment | 46 | Male | Chongqing |
Patient-5, Chronic hepatitis B, under treatment | 62 | Female | Chongqing |
Resident-1 | 61 | Female | Chengdu |
Resident-2 | 57 | Female | Chongqing |
Resident-3 | 62 | Male | Chengdu |
Resident-4 | 80 | Female | Chongqing |
Resident-5 | 43 | Female | Chengdu |
Resident-6 | 56 | Female | Chengdu |
CHC-1, Community Health Service Center Manager | 33 | Male | Chengdu |
CHC-2, Community Health Service Center Manager | 48 | Female | Chongqing |
CHC-3, Community Health Service Center worker | 42 | Female | Chongqing |
CHC-4, Doctor from community health service center | 27 | Male | Chengdu |
Community leader-1, Community manager | 38 | Female | Chengdu |
Community leader-2, Community manager | 54 | Male | Chengdu |
CDC-1, Infectious Disease Prevention and Control Section | 49 | Female | Chongqing |
CDC-2, STD/AIDS Prevention and Control Department | 39 | Female | Chongqing |
CDC-3, Department of Immunization Planning | 37 | Female | Chongqing |
CDC-4, Infectious Disease Prevention and Control Department | 42 | Male | Chongqing |
CDC-5, Infectious Disease Prevention and Control Department | 55 | Male | Chengdu |
CDC-6, Infectious Disease Prevention and Control Department | 38 | Female | Chengdu |
NGO-1, Community health promotion organization | 54 | Female | Chongqing |
NGO-2, AIDS prevention and control organization | 50 | Male | Chongqing |
NGO-3, AIDS prevention and control organization | 37 | Male | Chongqing |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Li, T.; Su, S.; Zhao, Y.; Deng, R.; Fan, M.; Wang, R.; Sharma, M.; Zeng, H. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. Int. J. Environ. Res. Public Health 2019, 16, 231. https://doi.org/10.3390/ijerph16020231
Li T, Su S, Zhao Y, Deng R, Fan M, Wang R, Sharma M, Zeng H. Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. International Journal of Environmental Research and Public Health. 2019; 16(2):231. https://doi.org/10.3390/ijerph16020231
Chicago/Turabian StyleLi, Tingting, Shu Su, Yong Zhao, Runze Deng, Mingyue Fan, Ruoxi Wang, Manoj Sharma, and Huan Zeng. 2019. "Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research" International Journal of Environmental Research and Public Health 16, no. 2: 231. https://doi.org/10.3390/ijerph16020231
APA StyleLi, T., Su, S., Zhao, Y., Deng, R., Fan, M., Wang, R., Sharma, M., & Zeng, H. (2019). Barriers to the Prevention and Control of Hepatitis B and Hepatitis C in the Community of Southwestern China: A Qualitative Research. International Journal of Environmental Research and Public Health, 16(2), 231. https://doi.org/10.3390/ijerph16020231